Clinicopathological characteristics and prognosis of lung metastases from breast cancer

VernacularTitle:乳腺癌肺转移的临床病理特点及预后分析
Author: Danhua LI ; Bin ZHANG ; Wenwen GENG ; Xinrui LIANG ; Xuchen CAO
Publication Type:Journal Article
Keywords: Breast neoplasms; Neoplasm metastasis; Receptors; Prognosis
From: Chinese Journal of General Surgery 2013;(2):96-99
CountryChina
Language:Chinese
Abstract: Objective To investigate the clinicopathological characteristics and prognosis of lung metastases from breast cancer.Methods The clinical data of 119 breast cancer patients treated at our institution from January 2000 to January 2007 were retrospectively reviewed.Results Among 119 patients with lung metastasis,35.3％ was hormone receptor (HR) +/human epithelial growth factor receptor (HER2)-,17.6％ was HR +/HER2 +,21.8％ was HR-/HER2 + and 25.2％ was trriple negative breast cancer (TNBC).The rate of grade Ⅲ in triple negative breast cancer was higher than the other subtypes(P =0.016).The median overall survival was 60 months (9-141 months),the median time to lung metastases was 29 months (3-99 months),and the median survival after lung metastasis was 33 months (range,6-98 months).The 1-,2-,3-and 5-year survival rate was 72.9％,54.1％,35.1％ and 14.4％.Conclusions TNBC,number of lung metastases,time to lung metastases less than 24 months,and a history of systemic chemotherapy were important factors for prognosis of patients with lung metastases.